Navigation Links
EndyMed Medical Receives FDA Clearance for Painless, Non-invasive Anti-Wrinkle Treatment System
Date:8/21/2009

CAESAREA, Israel, August 17 /PRNewswire/ -- EndyMed Medical Ltd, an innovative developer of noninvasive, energy-based aesthetic treatment systems for the professional market, announced today the FDA clearance of the EndyMed PRO(TM) (previously Imagine), for the non-invasive treatment of facial wrinkles and rhytides.

The EndyMed PRO implements the third generation 3DEEP(TM) radio frequency (RF) technology which uses multiple, phase controlled sources, and is the first product of this type to receive clearance to be marketed in the USA.

3DEEP(TM) uniquely controls the power, depth and 3-dimensional pattern of RF energy delivered to the skin. The 3DEEP technology results in minimal surface energy flow, thus eliminating the need for cooling, and providing an effective contouring treatment that is personalized, safe & totally painless.

"FDA clearance establishes our company as a significant player in the worldwide aesthetics market," said Uzi Blumensohn, EndyMed CEO. "Our 3DEEP Technology platform is proven to be highly effective in the treatment of facial wrinkles and importantly, has long-lasting effects, an important benefit for both physicians and their patients."

In a multicenter clinical study examining the safety and efficacy of the EndyMed PRO(TM) wrinkle reduction system, dermatological evaluation concluded that a significant reduction of wrinkle grading was evidenced in more than 80 percent of the treated patients, three months after the end of the treatment.

The advanced EndyMed PRO is equipped with a range of features to assure effective and safe treatment:

    - Non-invasive, yet highly effective therapy for the reduction of
      wrinkles and rhytides.
    - Customized treatment parameters
    - Optimal safety, with no pain and no side effects
    - Short treatment with no downtime
    - Noticeable immediate improvement
    - Long term results

About EndyMed Medical

EndyMed Medical Ltd., established in 2007, is a medical technology company that designs, develops, and commercializes noninvasive, RF-energy based aesthetic treatment systems for the professional market. EndyMed was established and continues to be guided by an experienced management, clinical and development team. The company is characterized by its fast, innovative, market-oriented R&D, targeting the fastest growing segments of the medical aesthetic market. The EndyMed PRO will be marketed exclusively in the United States by Eclipsemed Ltd, (http://www.eclipsemed.com), a leading distributor of aesthetic high-tech medical devices and supplies.

    Visit our web site:http://www.endymed.com
    For more information, please contact:
    Sandra Ziv
    +972-54-8051001
    sandraz@endymed.com



'/>"/>
SOURCE EndyMed Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Eclipsemed, Ltd to Introduce EndyMed PRO(TM) to U.S. Aesthetic Market
2. Elizabeth McCaughey Resigns As Director of Cantel Medical
3. Symmetry Medical to Present at Thomas Weisel Partners 2009 Healthcare Conference
4. Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
5. Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time
6. Medical Heroin Helps Treatment-Resistant Addicts
7. How Well Do You Sleep At Night? Visit The New Online Aviisha Medical Wellness Institute To Find Out
8. Rapid Fire Marketing Enters Medical Cannabis Business
9. Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. American Podiatric Medical Association Corrects Presidents Misstatement on Foot Amputation Costs
11. Johnson City Medical Center Saves $550,000 with Smart Square(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: